Evidence for Kidney Benefits Clinical trials show consistent kidney benefits: FLOW trial (semaglutide): This dedicated kidney outcome trial showed semaglutide reduced the risk of major kidney outcomes (kidney failure, significant decline in kidney function, or kidney-related death) by 24% in diabetic patients with chronic kidney disease
doi: 10.1016/j.neuroscience.2018.02.019
The researchers searched for the RCTs from a number of databases, including PubMed, EMBASE, Cochrane, and CINAHL
If you're feeling extremely thirsty, dizzy, or lightheaded, seek medical attention
GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider
oleifera seeds called myrosinase, which can catalyze the production of isothiocyanates on plant damage or processing (84)